Yale University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Yale University sits in the top decile of US sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count).
Yale University: 1,492 sponsored US clinical trials, 254 recruiting.
Yale University sponsors 1,492 registered US clinical trials on ClinicalTrials.gov, 254 of them currently recruiting, and 1,005 completed. 99 of these trials are in Phase 3-4 (later-stage) and 579 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Opioid Use Disorder, with 19 trials.
Top-decile sponsor footprint
Yale University ranks in the top decile of sponsors by registered trial count (#13 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,005 of 1,138 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,492 total, page 23 of 30
The Effects of ∆-9-THC and Naloxone in Humans
NCT01591629
Plasma Angiopoietin Levels in Children Following Cardiopulmonary Bypass
NCT01489475
Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes
NCT01479998
Study of Modified FOLFIRINOX in Advanced Pancreatic Cancer
NCT01523457
Yale Pink and Blue Kids: Effects of Exposure During Pregnancy to Nicotine or Antidepressants in 4-8 Year Old Children
NCT01640600
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
NCT01456468
A Randomized Controlled Trial of Routine Shave Margins Versus Standard Partial Mastectomy in Breast Cancer Patients
NCT01452399
Screening to Augment Referral to Treatment- Project START
NCT01539525
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
NCT02193204
Tobacco Approach Avoidance Training for Adolescent Smokers-1
NCT01625767
Using Capnography to Reduce Hypoxia During Pediatric Sedation
NCT01463527
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
NCT01531153
Study to Evaluate the Health and Wellness Policies of the New Haven Public School District.
NCT02043626
The Effect of Sorafenib on Portal Pressure
NCT01714609
Emergency Department (ED) Disability Diagnostic Tool
NCT01416857
Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia
NCT01462227
Effectiveness and Cost Effectiveness of Peer Mentors in Reducing Hospital Use
NCT01566513
Genetics of Fatty Liver Disease in Children
NCT01966627
Acute Coronary Syndrome and Care-Seeking Delay: A Web Based Behavioral Study
NCT01407146
Efficacy and Tolerability of Riluzole in Treatment Resistant Depression
NCT01204918
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer
NCT01367002
Evaluation of the Effect of Hypoglycemia With PET and a Norepinephrine Transporter Ligand
NCT02056249
Fathers for Change for Men With Co-occurring Domestic Violence and Substance Abuse
NCT01385553
Continuous Versus Intermittent Dosing Regimens for Pomalidomide in Relapsed/Refractory Multiple Myeloma
NCT01319422
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
NCT01446913
Study to Investigate Benefits of Weight Loss in Young Adults and Adolescents
NCT01901978
Cognitive-Behavioral Therapy for Irritability in Adolescents With High Functioning Autism Spectrum Disorder
NCT01631851
Limit Computed Tomography (CT) Scanning in Suspected Renal Colic
NCT01352676
An Open-Label Pilot Trial of Alpha Lipoic Acid (ALA) for Weight Loss in Schizophrenia
NCT01355952
Facts-Up-Front Versus Traffic-Light Food Labels
NCT01626729
Family Health and Development Project
NCT01567969
The Relationship Between Positive End Expiratory Pressure and Cardiac Index in Patients With Acute Respiratory Distress Syndrome (ARDS) Managed on a Fluid Protocol
NCT01714583
Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention
NCT01227044
Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment
NCT01334580
Calcitonin for Treating X-linked Hypophosphatemia
NCT01652573
Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations
NCT01246401
Effects of Transcranial Direct Current Stimulation on Tobacco Withdrawal Symptoms
NCT01567982
Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery
NCT01298167
Progesterone for Postpartum Cocaine Relapse
NCT01249274
Kappa-PET Imaging and Naltrexone in Alcohol Drinking Behaviors
NCT01625611
A Smoking Cessation Treatment for Adult Women
NCT01422239
Alcohol Counseling for Telephone Quitline Callers
NCT01120080
Lifestyle, Exercise and Nutrition Study 1
NCT02109068
Hepatic De Novo Lipogenesis (DNL)in the Pathogenesis of Hepatic Steatosis in Obese Youth
NCT01725035
Cognitive Remediation and Work Therapy in the Initial Phase of Substance Abuse Treatment
NCT01410110
Smoking Cessation for Smokers With Sleep Problems
NCT01277887
Treating Low-Income Smokers in the Hospital Emergency Department
NCT01328431
Hydronephrosis on Ultrasound With CT Finding in Patients With Renal Colic
NCT01349244
Decreasing Stress and Improving Self-control With "Stress in Control" (Sync) Training
NCT01721499
Randomized Trial of Parent Training for Young Children With Autism
NCT01233414
What is open in the Yale University pipeline
254 recruiting of 1,492 indexed (17% open); 1,005 completed (67%).
Phase mix: 99 late (III/IV) vs 579 early (I/II) (early-phase heavy).
Top condition: Opioid Use Disorder (19 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Yale University: open-pipeline peers nationwide
Peers matched on 1,492 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
Yale University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,492 trials (± recruiting share)
- Washington University School of Medicine · 1,502 trials · 14% recruiting
- Johns Hopkins University · 1,448 trials · 17% recruiting
- University of Pennsylvania · 1,423 trials · 14% recruiting
- Novartis Pharmaceuticals · 1,375 trials · 8% recruiting
Sponsors near 17% open enrollment (± trial volume)
- NYU Langone Health · 17% recruiting · 1,164 trials
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
Related
What to do with this Yale University page
1,492 registered trials is a research-attention snapshot, not an endorsement of Yale University or any single study.
- 254 of Yale University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Opioid Use Disorder is the condition Yale University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Opioid Use Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Yale University pipeline card: 1,492 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.